Best practices: Appropriate use of the new β-lactam/ β-lactamase inhibitor combinations, ceftazidimeavibactam and ceftolozane-tazobactam in South Africa.

Autor: Brink, Adrian J., Coetzee, ennifer, Richards, Guy A., Feldman, Charles, Lowman, Warren, Tootla, Hafsah D., Miller, Malcolm G.A., Niehaus, Abraham J., Wasserman, Sean, Perovic, Olga, Govind, Chetna N., Schellack, Natalie, Mendelson, Marc

Publikováno v: Southern African Journal of Infectious Diseases; 2022, Vol. 37 Issue 1, p1-10, 10p, 1 Diagram, 5 Charts